Hainan Haiyao Pays $10 Million for SinoMab Stake
By: ChinaBio® Today
Hainan Haiyao Co. will pay $9.9 million for a 40% stake in SinoMab Bioscience Limited, a company that is headquartered in Hong Kong with offices and manufacturing facilities in Shenzhen. When the purchase is completed, Haiyao will be SinoMab’s largest shareholder. SinoMab was founded in 2001 and is seeking to discover therapeutic antibodies that treat life-threatening and debilitating diseases. More details.... Stock Symbol: (SHE: 000566) Share this with colleagues: // //
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here